GlassScriptPhysician profile
Om Dawani
NPI 1699127290
$5,695.86
in general payments reported to CMS, 2019-2025
17 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $103 · 2021: $897 · 2022: $1,147 · 2023: $206 · 2024: $2,683 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $1,137 · Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $1,137.45 |
| Food and Beverage | $575.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,045.77 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $610.67 | 2019-2025 | |
| Glaxosmithkline, LLC. | $438.52 | 2021-2023 | Nucala |
| Regeneron Healthcare Solutions, INC. | $431.68 | 2021-2025 | Dupixent |
| Genzyme Corporation | $209.38 | 2021-2023 | |
| Amgen INC. | $167.53 | 2021-2022 | |
| Csl Behring | $141.31 | 2022-2023 | Kcentra |
| Janssen Pharmaceuticals, INC | $116.28 | 2019 | |
| Shionogi INC | $98.70 | 2022 | |
| Insmed, INC. | $95.98 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.04 | 2020 | |
| Merck Sharp & Dohme LLC | $84.83 | 2019 | |
| Astellas Pharma US INC | $79.99 | 2022 | |
| Genentech USA, INC. | $40.08 | 2019 | |
| Alexion Pharmaceuticals, INC. | $17.48 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.52 | 2020 | |
| Edwards Lifesciences Corporation | $15.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Om Dawani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.